Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Iridex's IQ laser systems cleared by FDA

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Iridex's IQ family of laser systems. It includes the IQ 532 (green spectrum), IQ 577 (yellow), IQ 630-670 (red) and IQ 810 (infrared) systems, which are used for a wide range of applications including ophthalmology, otolaryngology (ear, nose and throat) and dermatology. For example, the 532nm laser can correct certain types of hearing loss, while 810nm lasers can treat glaucoma. Mountain View, California-based Iridex will launch the IQ 577 yellow light laser first, which it says provides a wavelength and technology that is not commercially available from any of its competitors. It can deliver light in a continuous wave or MicroPulse, tissue-sparing, mode.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel